European Companies Search Engine
EU funding (€3,835,853): PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis Hor16 Sept 2020 EU Research and Innovation programme "Horizon"
Text
PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis
Prematurity exponentially increases the risk for an altered neurodevelopmental outcomes in childhood and adolescence. Many survivors children, face a lifetime of disability. Despite the advances in neonatal care have greatly improved survival of preterm born infants even at extremely low gestational ages we are now at a period of steadiness where no further improvement in long-term neurodevelopmental outcome is seen. The impact of these sequelae affects not only at a personal and familiar level but also poses a significant burden on society. Early diagnostics of brain injury and/or brain dysmaturation as well as early detection of impairments are important strategies to improve the well-being of children and their families allowing for developmental monitoring and medical evaluation of the specific type of disorder that affects a child and optimize therapeutics options. In this context, PARENT is a vision for a multidisciplinary approach to develop diagnostic and predictive platforms focused on newborn motor/cognitive impairments. PARENT will make a critical contribution towards an open neurodevelopmental disease diagnostic software infrastructure by interlinking disciplines from clinical data, neuroimaging collection and processing, biomarkers, data fusion, machine learning applied to clinical data, novel prediction algorithms. To best leverage the data potential, PARENT envisions an easy-to-use software infrastructure which provides integrated databases, validated algorithms components and platforms built upon them. This vision can be included in the more general paradigm of evidence-based medicine, personalized medicine and patient center care, as well as decision support systems in clinical field. PARENT combines the efforts of a multidisciplinary network of 10 leading European research groups, industry partners, pediatric hospitals and parents’ association to develop a technological infrastructure that will train 15 Early Stage Researchers.
Funded Companies:
| Company name | Funding amount |
| 7HC Srl | €261,500 |
| Fundación para La Gestión de La Investigación Biomédica de Cádiz | €501,810 |
| GPI S.p.A. | €261,500 |
| Icometrix N.V. | €256,320 |
| Katholieke Universiteit Leuven | €256,320 |
| Neus Diagnostics, Raziskave IN Razvoj Medicinske Opreme d.o.o. | €239,957 |
| Ospedale Pediatrico Bambino Gesu | €261,500 |
| Politecnico Di Torino | €522,999 |
| TOELT GmbH | €281,277 |
| Universidad de Cadiz | €752,715 |
| Univerza V Ljubljani | €239,957 |
Source: https://cordis.europa.eu/project/id/956394
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "7HC Srl - EU funding (€3,835,853): PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
